UPLC/Q‐TOF–MS‐based metabolomics evaluate the efficacy of oroxylin A against postmenopausal osteoporosis
Authors:
- 5 March 2023
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 37 (5) , e5609
Abstract
Post‐menopausal osteoporosis (PMOP) is a common metabolic bone malady characterized by bone mass loss and bone microarchitectural deterioration; however, there is currently no effective drug for its management. According to our previous study, oroxylin A (OA) could effectively protect ovariectomized (OVX)‐osteoporotic mice from bone loss; however, its therapeutic targets are still unclear. From a metabolomic perspective, we studied serum metabolic profiles to discover potential biomarkers and OVX‐related metabolic networks, which could assist us to comprehend the impact of OA on OVX. Five metabolites were identified as biomarkers associated with 10 related metabolic pathways, including phenylalanine, tyrosine and tryptophan biosynthesis, and phenylalanine, tryptophan and glycerophospholipid metabolism. After OA treatment, the expression of multiple biomarkers changed, with lysophosphatidylcholine (18:2) being a major significantly regulated biomarker. Our study demonstrated that OA's effects on OVX are probably related to the regulation of phenylalanine, tyrosine and tryptophan biosynthesis. Our findings explain the role of OA against PMOP in terms of metabolism and pharmacology and provide a pharmacological foundation for OA treatment of PMOP.Keywords
Funding Information
- Natural Science Foundation of Guangxi Province (2021GXNSFAA196038)
- Specific Research Project of Guangxi for Research Bases and Talents (GuikeAD19254003)
This publication has 41 references indexed in Scilit:
- Association between bile acid turnover and osteoporosis in postmenopausal womenNuclear Medicine Communications, 2013
- High-calcium, vitamin D fortified milk is effective in improving bone turnover markers and vitamin D status in healthy postmenopausal Chinese womenEuropean Journal of Clinical Nutrition, 2012
- Metabonomic study on the anti-osteoporosis effect of Rhizoma Drynariae and its action mechanism using ultra-performance liquid chromatography–tandem mass spectrometryJournal of Ethnopharmacology, 2012
- Reactive oxygen species on bone mineral density and mechanics in Cu,Zn superoxide dismutase (Sod1) knockout miceBiochemical and Biophysical Research Communications, 2010
- The role of Dkk1 in bone mass regulation: Correlating serum Dkk1 expression with bone mineral densityJournal of Orthopaedic Research, 2010
- Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosisRheumatology International, 2007
- Allosteric activation of the extracellular Ca2+-sensing receptor byL-amino acids enhances ERK1/2 phosphorylationBiochemical Journal, 2007
- Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogsBone, 2006
- Inhibition of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative, SCOHBiochemical Pharmacology, 2004
- Expression of Serotonin Receptors in BoneJournal of Biological Chemistry, 2001